Litcius/Paper detail

Flawed ivermectin preprint highlights challenges of COVID drug studies

Sara Reardon

2021Nature82 citationsDOI

Topics & Concepts

PreprintCoronavirus disease 2019 (COVID-19)IvermectinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrugVirologyMedicinePharmacologyComputer scienceInternal medicineInfectious disease (medical specialty)Veterinary medicineWorld Wide WebOutbreakDiseaseParasitic Diseases Research and TreatmentSocial Media in Health EducationMobile Health and mHealth Applications
Flawed ivermectin preprint highlights challenges of COVID drug studies | Litcius